Contents

Current Pharmaceutical Design, Volume 10 - Number 25

Preface [Hot Topic: Novel Immunomodulatory Effects of Macrolides in Inflammatory Lung Disease (Executive Editors: F. Martinez and T.J. Standiford)]

, 10(25): i

Fernando Martinez and Theodore J. Standiford


DOI: 10.2174/1381612043383395




Preface [Hot Topic: Current Trends in the Development of Acetylcholinesterase Inhibitors as Anti-Alzheimer Agents (Executive Editors: P. Camps and D. Munoz-Torrero)]

, 10(25): iii

Pelayo Camps and Diego Munoz-Torrero


DOI: 10.2174/1381612810409020iii




The Macrolide Antibiotics: A Pharmacokinetic and Pharmacodynamic Overview

, 10(25): 3045 - 3053

R. Jain and L. H. Danziger


DOI: 10.2174/1381612043383322




Regulatory Effects of Macrolides on Bacterial Virulence: Potential Role as Quorum-Sensing Inhibitors

, 10(25): 3055 - 3065

Kazuhiro Tateda, Theodore J. Standiford, Jean Claude Pechere and Keizo Yamaguchi


DOI: 10.2174/1381612043383377




Cellular and Molecular Effects of Macrolides on Leukocyte Function

, 10(25): 3067 - 3080

Marie-Therese Labro


DOI: 10.2174/1381612043383403




Immunomodulatory Effects of Macrolides in the Lung: Lessons from In- Vitro and In-Vivo Models

, 10(25): 3081 - 3093

Wan C. Tsai and Theodore J. Standiford


DOI: 10.2174/1381612043383430




Clinical Implications of Macrolide Therapy in Chronic Sinopulmonary Diseases

, 10(25): 3095 - 3110

Fernando J. Martinez and Richard H. Simon


DOI: 10.2174/1381612043383304




Rationale for the Development of Cholinesterase Inhibitors as Anti- Alzheimer Agents

, 10(25): 3111 - 3119

D. K. Lahiri, J. T. Rogers, N. H. Greig and K. Sambamurti


DOI: 10.2174/1381612043383331




An Overview of the Current and Novel Drugs for Alzheimers Disease with Particular Reference to Anti-Cholinesterase Compounds

, 10(25): 3121 - 3130

Marcela Colombres, Juan Paulo Sagal and Nibaldo C. Inestrosa


DOI: 10.2174/1381612043383359




Molecular Modelling Approaches to the Design of Acetylcholinesterase Inhibitors: New Challenges for the Treatment of Alzheimers Disease

, 10(25): 3131 - 3140

J. Munoz-Muriedas, J. M. Lopez, Modesto Orozco and F. Javier Luque


DOI: 10.2174/1381612043383386




Development of Bivalent Acetylcholinesterase Inhibitors as Potential Therapeutic Drugs for Alzheimers Disease

, 10(25): 3141 - 3156

Da-Ming Du and Paul R. Carlier


DOI: 10.2174/1381612043383412




Acetylcholinesterase Inhibitors as a Starting Point Towards Improved Alzheimers Disease Therapeutics

, 10(25): 3157 - 3166

Maurizio Recanatini and Piero Valenti


DOI: 10.2174/1381612043383313




Recent Approaches to Novel Anti-Alzheimer Therapy

, 10(25): 3167 - 3175

Carreiras M. C. and Marco J. L.


DOI: 10.2174/1381612043383421




New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimers Disease

, 10(25): 3177 - 3184

M. Villarroya, A. G. García and J. L. Marco


DOI: 10.2174/1381612043383368




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science